MolNFT v1 · #10661 · protein

Crystal structure of cpa and sulfamide-based inhibitor complex

1IY7 · Carboxypeptidase a: “Crystal structure of cpa and sulfamide-based inhibitor complex”. X-ray diffraction, 2 ligands (CXA, ZN), 1 pocket (best druggability 0.63). MolNFT v1 #10661 on GenesisL1: 3D structure, binding sites and pockets…

PDB: 1IY7
Type: protein
Length: 307 residues
Chains: 1
Method: x-ray diffraction
Collection: MolNFT v1 / PDB
Contract: 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner: 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule: Carboxypeptidase a
EC: 3.4.17.1
UniProt: P00730
Ligands: CXA, ZN
Pockets: 1 · best druggability 0.63

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 18% strand (DSSP).

Chain	Molecule	Type	Residues	Secondary structure	UniProt
A	Carboxypeptidase a (EC 3.4.17.1)	protein	307	38% helix, 18% strand	P00730

Ligands and binding sites

CXA · Phenylalanine-N-sulfonamide · ligand · chains A
ZN · Zinc ion · metal · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

Pocket	Volume (Å³)	Druggability	Buriedness	Lining residues	Inside
1	91	0.63	0.90	25	CXA

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

1IY7 · Crystal Structure of CPA and sulfamide-based inhibitor complex · the same entry in another collection · chain A against A, TM-score 1.00
P00730 · AlphaFold monomer V2.0 prediction for carboxypeptidase A1 (P00730) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
Every structure of UniProt P00730
Elsewhere: RCSB PDB 1IY7 · PDBe 1IY7 · UniProt P00730

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.